Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naïve CD4+ T cells.

Nicoli F, Gallerani E, Sforza F, Finessi V, Chachage M, Geldmacher C, Cafaro A, Ensoli B, Caputo A, Gavioli R.

AIDS. 2018 Mar 13;32(5):575-581. doi: 10.1097/QAD.0000000000001734.

PMID:
29280760
2.

Rational Design of Nucleoside-Bile Acid Conjugates Incorporating a Triazole Moiety for Anticancer Evaluation and SAR Exploration.

Navacchia ML, Marchesi E, Mari L, Chinaglia N, Gallerani E, Gavioli R, Capobianco ML, Perrone D.

Molecules. 2017 Oct 12;22(10). pii: E1710. doi: 10.3390/molecules22101710.

3.

Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.

Marastoni M, Trapella C, Scotti A, Fantinati A, Ferretti V, Marzola E, Eleonora G, Gavioli R, Preti D.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):865-877. doi: 10.1080/14756366.2017.1334649.

4.

Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (II) carboxylates.

Sguizzato M, Cortesi R, Gallerani E, Drechsler M, Marvelli L, Mariani P, Carducci F, Gavioli R, Esposito E, Bergamini P.

Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:357-364. doi: 10.1016/j.msec.2016.12.020. Epub 2016 Dec 7.

PMID:
28254304
5.

AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions.

Zamariola G, Watly J, Gallerani E, Gavioli R, Guerrini R, Kozlowski H, Remelli M.

J Inorg Biochem. 2016 Oct;163:301-310. doi: 10.1016/j.jinorgbio.2016.04.001. Epub 2016 Apr 8.

PMID:
27087285
6.

Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.

Nicoli F, Chachage M, Clowes P, Bauer A, Kowour D, Ensoli B, Cafaro A, Maboko L, Hoelscher M, Gavioli R, Saathoff E, Geldmacher C.

BMC Infect Dis. 2016 Jul 22;16:344. doi: 10.1186/s12879-016-1647-3.

7.

Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.

Nicoli F, Gallerani E, Skarlis C, Sicurella M, Cafaro A, Ensoli B, Caputo A, Marconi PC, Gavioli R.

Vaccine. 2016 Apr 27;34(19):2216-24. doi: 10.1016/j.vaccine.2016.03.022. Epub 2016 Mar 19.

PMID:
27002499
8.

UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.

Iizuka Y, Cichocki F, Sieben A, Sforza F, Karim R, Coughlin K, Isaksson Vogel R, Gavioli R, McCullar V, Lenvik T, Lee M, Miller J, Bazzaro M.

J Immunol. 2015 Nov 15;195(10):4760-70. doi: 10.4049/jimmunol.1500979. Epub 2015 Oct 5.

9.

Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.

Scotti A, Trapella C, Ferretti V, Gallerani E, Gavioli R, Marastoni M.

J Enzyme Inhib Med Chem. 2016;31(3):456-63. doi: 10.3109/14756366.2015.1037749. Epub 2015 May 5.

PMID:
25942361
10.

Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.

Finessi V, Nicoli F, Gallerani E, Sforza F, Sicurella M, Cafaro A, Caputo A, Ensoli B, Gavioli R.

Hum Vaccin Immunother. 2015;11(6):1489-93. doi: 10.1080/21645515.2015.1016676.

11.

Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs.

Nicoli F, Sforza F, Gavioli R.

AIDS. 2015 Jan 2;29(1):133-4. doi: 10.1097/QAD.0000000000000514. No abstract available.

PMID:
25562499
12.

An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.

Sicurella M, Nicoli F, Gallerani E, Volpi I, Berto E, Finessi V, Destro F, Manservigi R, Cafaro A, Ensoli B, Caputo A, Gavioli R, Marconi PC.

PLoS One. 2014 Jul 17;9(7):e100844. doi: 10.1371/journal.pone.0100844. eCollection 2014.

13.

HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors.

Sforza F, Nicoli F, Gallerani E, Finessi V, Reali E, Cafaro A, Caputo A, Ensoli B, Gavioli R.

AIDS. 2014 Jul 31;28(12):1729-38. doi: 10.1097/QAD.0000000000000315.

PMID:
24841128
14.

Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors.

Marastoni M, Scotti A, Trapella C, Ferretti V, Sforza F, Gavioli R.

J Pept Sci. 2014 Apr;20(4):258-65.

PMID:
24677765
15.

The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.

Nicoli F, Finessi V, Sicurella M, Rizzotto L, Gallerani E, Destro F, Cafaro A, Marconi P, Caputo A, Ensoli B, Gavioli R.

PLoS One. 2013 Nov 4;8(11):e77746. doi: 10.1371/journal.pone.0077746. eCollection 2013.

16.

Lysis-on-chip of single target cells following forced interaction with CTLs or NK cells on a dielectrophoresis-based array.

Abonnenc M, Borgatti M, Fabbri E, Gavioli R, Fortini C, Destro F, Altomare L, Manaresi N, Medoro G, Romani A, Tartagni M, Lo Monaco E, Giacomini P, Guerrieri R, Gambari R.

J Immunol. 2013 Oct 1;191(7):3545-52. doi: 10.4049/jimmunol.1300890. Epub 2013 Sep 4.

17.

Novel oleanolic vinyl boronates: synthesis and antitumor activity.

Moreira VM, Salvador JA, Simões S, Destro F, Gavioli R.

Eur J Med Chem. 2013 May;63:46-56. doi: 10.1016/j.ejmech.2013.01.040. Epub 2013 Feb 9.

PMID:
23455056
18.

C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors.

Franceschini C, Trapella C, Calia R, Scotti A, Sforza F, Gavioli R, Marastoni M.

J Enzyme Inhib Med Chem. 2013 Oct;28(5):1034-9. doi: 10.3109/14756366.2012.709241. Epub 2012 Aug 7.

PMID:
22871133
19.

Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides.

Franceschini C, Trapella C, Sforza F, Gavioli R, Marastoni M.

J Enzyme Inhib Med Chem. 2013 Jun;28(3):560-4. doi: 10.3109/14756366.2012.657189. Epub 2012 Mar 1.

PMID:
22380778
20.

Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.

Anchoori RK, Khan SR, Sueblinvong T, Felthauser A, Iizuka Y, Gavioli R, Destro F, Isaksson Vogel R, Peng S, Roden RB, Bazzaro M.

PLoS One. 2011;6(8):e23888. doi: 10.1371/journal.pone.0023888. Epub 2011 Aug 31.

21.

Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.

Destro F, Sforza F, Sicurella M, Marescotti D, Gallerani E, Baldisserotto A, Marastoni M, Gavioli R.

Immunology. 2011 May;133(1):105-14. doi: 10.1111/j.1365-2567.2011.03416.x. Epub 2011 Feb 22.

22.

α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

Bazzaro M, Anchoori RK, Mudiam MK, Issaenko O, Kumar S, Karanam B, Lin Z, Isaksson Vogel R, Gavioli R, Destro F, Ferretti V, Roden RB, Khan SR.

J Med Chem. 2011 Jan 27;54(2):449-56. doi: 10.1021/jm100589p. Epub 2010 Dec 27.

23.

IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.

Lattanzi L, Rozera C, Marescotti D, D'Agostino G, Santodonato L, Cellini S, Belardelli F, Gavioli R, Ferrantini M.

Immunobiology. 2011 May;216(5):537-47. doi: 10.1016/j.imbio.2010.10.003. Epub 2010 Oct 21.

PMID:
21093097
24.

The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress.

Preta G, de Klark R, Gavioli R, Glas R.

J Oncol. 2010;2010. pii: 128478. doi: 10.1155/2010/128478. Epub 2010 Aug 18.

25.

Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides.

Baldisserotto A, Franceschini C, Scalambra F, Trapella C, Marastoni M, Sforza F, Gavioli R, Tomatis R.

J Pept Sci. 2010 Nov;16(11):659-63. doi: 10.1002/psc.1280.

PMID:
20814885
26.

Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides.

Bortolini O, De Nino A, Eliseo T, Gavioli R, Maiuolo L, Russo B, Sforza F.

Bioorg Med Chem. 2010 Oct 1;18(19):6970-6. doi: 10.1016/j.bmc.2010.08.024. Epub 2010 Aug 14.

PMID:
20813537
27.

Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.

Baldisserotto A, Ferretti V, Destro F, Franceschini C, Marastoni M, Gavioli R, Tomatis R.

J Med Chem. 2010 Sep 9;53(17):6511-5. doi: 10.1021/jm100122e.

PMID:
20687609
28.

Altered miRNA expression in T regulatory cells in course of multiple sclerosis.

De Santis G, Ferracin M, Biondani A, Caniatti L, Rosaria Tola M, Castellazzi M, Zagatti B, Battistini L, Borsellino G, Fainardi E, Gavioli R, Negrini M, Furlan R, Granieri E.

J Neuroimmunol. 2010 Sep 14;226(1-2):165-71. doi: 10.1016/j.jneuroim.2010.06.009. Epub 2010 Jul 16.

PMID:
20637509
29.

Effects of biomaterials for Lab-on-a-chip production on cell growth and expression of differentiated functions of leukemic cell lines.

Destro F, Borgatti M, Iafelice B, Gavioli R, Braun T, Bauer J, Böttcher L, Jung E, Bocchi M, Guerrieri R, Gambari R.

J Mater Sci Mater Med. 2010 Sep;21(9):2653-64. doi: 10.1007/s10856-010-4125-2. Epub 2010 Jul 13.

PMID:
20625835
30.

Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.

Marescotti D, Destro F, Baldisserotto A, Marastoni M, Coppotelli G, Masucci M, Gavioli R.

Immunology. 2010 Mar;129(3):386-95. doi: 10.1111/j.1365-2567.2009.03190.x. Epub 2009 Nov 16.

31.

HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.

Caputo A, Gavioli R, Bellino S, Longo O, Tripiciano A, Francavilla V, Sgadari C, Paniccia G, Titti F, Cafaro A, Ferrantelli F, Monini P, Ensoli F, Ensoli B.

Int Rev Immunol. 2009;28(5):285-334. doi: 10.1080/08830180903013026. Review.

PMID:
19811313
32.

N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors.

Baldisserotto A, Destro F, Vertuani G, Marastoni M, Gavioli R, Tomatis R.

Bioorg Med Chem. 2009 Aug 1;17(15):5535-40. doi: 10.1016/j.bmc.2009.06.025. Epub 2009 Jun 18.

PMID:
19577931
33.

Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration.

Caputo A, Castaldello A, Brocca-Cofano E, Voltan R, Bortolazzi F, Altavilla G, Sparnacci K, Laus M, Tondelli L, Gavioli R, Ensoli B.

Vaccine. 2009 Jun 2;27(27):3605-15. doi: 10.1016/j.vaccine.2009.03.047. Epub 2009 Apr 7.

PMID:
19464541
34.

Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.

Voltan R, Castaldello A, Brocca-Cofano E, De Michele R, Triulzi C, Altavilla G, Tondelli L, Laus M, Sparnacci K, Reali E, Gavioli R, Ensoli B, Caputo A.

Vaccine. 2009 Jul 16;27(33):4498-507. doi: 10.1016/j.vaccine.2009.05.031. Epub 2009 May 28.

PMID:
19450649
35.

New cyclic peptide proteasome inhibitors.

Baldisserotto A, Marastoni M, Gavioli R, Tomatis R.

Bioorg Med Chem Lett. 2009 Apr 1;19(7):1966-9. doi: 10.1016/j.bmcl.2009.02.046. Epub 2009 Feb 14.

PMID:
19250821
36.

Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.

Preta G, Marescotti D, Fortini C, Carcoforo P, Castelli C, Masucci M, Gavioli R.

Scand J Immunol. 2008 Dec;68(6):579-88. doi: 10.1111/j.1365-3083.2008.02175.x. Epub 2008 Oct 22.

37.

Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice.

Cellini S, Fortini C, Gallerani E, Destro F, Cofano EB, Caputo A, Gavioli R.

Virol J. 2008 Jul 14;5:81. doi: 10.1186/1743-422X-5-81.

38.

Vinyl ester-based cyclic peptide proteasome inhibitors.

Baldisserotto A, Marastoni M, Fiorini S, Pretto L, Ferretti V, Gavioli R, Tomatis R.

Bioorg Med Chem Lett. 2008 Mar 15;18(6):1849-54. doi: 10.1016/j.bmcl.2008.02.016. Epub 2008 Feb 10.

PMID:
18294845
39.

Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.

Caputo A, Brocca-Cofano E, Castaldello A, Voltan R, Gavioli R, Srivastava IK, Barnett SW, Cafaro A, Ensoli B.

Vaccine. 2008 Feb 26;26(9):1214-27. doi: 10.1016/j.vaccine.2007.12.030. Epub 2008 Jan 15.

PMID:
18243435
40.

The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.

Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, Fortini C, Cofano EB, Triulzi C, Cafaro A, Srivastava I, Barnett S, Caputo A, Ensoli B.

Vaccine. 2008 Jan 30;26(5):727-37. Epub 2007 Dec 4.

PMID:
18096278
41.

C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors.

Baldisserotto A, Marastoni M, Lazzari I, Trapella C, Gavioli R, Tomatis R.

Eur J Med Chem. 2008 Jul;43(7):1403-11. Epub 2007 Oct 7.

PMID:
17996987
42.

Prevalence of antibodies to Bartonella henselae in dogs in Italy.

Di Francesco A, Sanguinetti V, Gallina L, Gavioli R, Piva S, Baldelli R.

Vet Rec. 2007 Oct 6;161(14):489-90. No abstract available.

PMID:
17921442
43.

Phosphinic platinum complexes with 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity.

Bergamini P, Bertolasi V, Marvelli L, Canella A, Gavioli R, Mantovani N, Mañas S, Romerosa A.

Inorg Chem. 2007 May 14;46(10):4267-76. Epub 2007 Apr 20.

PMID:
17444631
44.

Problems and emerging approaches in HIV/AIDS vaccine development.

Titti F, Cafaro A, Ferrantelli F, Tripiciano A, Moretti S, Caputo A, Gavioli R, Ensoli F, Robert-Guroff M, Barnett S, Ensoli B.

Expert Opin Emerg Drugs. 2007 Mar;12(1):23-48. Review.

PMID:
17355212
45.

Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit.

Baldisserotto A, Marastoni M, Trapella C, Gavioli R, Ferretti V, Pretto L, Tomatis R.

Eur J Med Chem. 2007 May;42(5):586-92. Epub 2007 Jan 9.

PMID:
17291631
46.

Down-regulation of proteolytic complexes following EBV activation in BL cells.

Matusali G, De Leo A, Gavioli R, Bertelli L, Di Renzo L, Mattia E.

Biochem Biophys Res Commun. 2007 Jan 26;352(4):947-52. Epub 2006 Dec 4.

PMID:
17157806
47.

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination.

Castaldello A, Brocca-Cofano E, Voltan R, Triulzi C, Altavilla G, Laus M, Sparnacci K, Ballestri M, Tondelli L, Fortini C, Gavioli R, Ensoli B, Caputo A.

Vaccine. 2006 Jul 17;24(29-30):5655-69. Epub 2006 Jun 2.

PMID:
16781023
48.

Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors.

Marastoni M, Baldisserotto A, Trapella C, Gavioli R, Tomatis R.

Eur J Med Chem. 2006 Aug;41(8):978-84. Epub 2006 May 18.

PMID:
16713026
49.

P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors.

Marastoni M, Baldisserotto A, Trapella C, Gavioli R, Tomatis R.

Bioorg Med Chem Lett. 2006 Jun 15;16(12):3125-30. Epub 2006 Apr 5.

PMID:
16603348
50.

Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1.

Remoli AL, Marsili G, Perrotti E, Gallerani E, Ilari R, Nappi F, Cafaro A, Ensoli B, Gavioli R, Battistini A.

Biochem J. 2006 Jun 1;396(2):371-80.

Supplemental Content

Loading ...
Support Center